Sustaining healthy weight loss is about so much more than cutting calories or injecting drugs, as many GLP-1 users are ...
During the first poster session of the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer ...
Inhibrx Biosciences Inc.’s monoclonal antibody for treating advanced or metastatic, unresectable chondrosarcoma hit its primary endpoint in a registrational phase II study, doubling the company’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback